Aerovate Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Aerovate Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q2 2021 to Q3 2024.
  • Aerovate Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $81K, a 96.4% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $81K -$2.16M -96.4% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $81K -$2.15M -96.4% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $2.6M -$52K -1.96% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $2.28M -$276K -10.8% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $2.24M +$1.17M +109% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.23M +$1.5M +205% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.65M +$2.32M +710% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.56M +$2.26M +748% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $1.08M +$798K +287% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $731K -$2.36M -76.3% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $327K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $302K Dec 31, 2021 10-K 2023-03-29
Q3 2021 $278K Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $3.09M Jun 30, 2021 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.